Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:109 (10 January), doi:10.1136/bmj.328.7431.109
| The first 150 words of the full text of this article appear below. |
EDITORLi et al reported that use of non-steroidal anti-inflammatory drugs (NSAIDs) in the first half of pregnancy is associated with an 80% increased risk of miscarriage, which is in accordance with our previous results.1 2
We have since accessed a recent update of our dataset covering 1998-2002, including gestational age, which was not originally accessible.
We obtained data on miscarriage, and birth and drug exposure were obtained from a hospital discharge registry and a prescription database).2 We identified 1599 women with first recorded miscarriage, of whom 45 had filled prescriptions for NSAIDs in the last 12 weeks before the miscarriage. As controls we used 10 primigravidas delivering after the 28th gestational week in the corresponding gestational period (n = 15 990).
Cases and controls were classified as drug exposed if they had redeemed NSAID prescriptions at appropriate gestational periods. We assessed the association between miscarriage and NSAID use in
Gunnar Lauge Nielsen, consultant
uxgln@aas.nja.dk
Mette Vinther Skriver, biostatistician, Lars Pedersen, chief statistician, Henrik Toft Sørensen, professor
Department of Clinical Epidemiology, Aalborg and Aarhus University Hospitals, DK-9000 Aalborg, Denmark